EditForce completed fund raising by third-party allotment
Fukuoka, Japan, 7 May, 2021 – EditForce Inc. (“EditForce”) has announced that it has raised 800 million yen (approximately 7.27 million US dollars) by May 7, 2021, from the lead investor NEWTON BIOCAPITAL as well as other new and existing investors by third-party allotment.
Investors:
- NEWTON BIOCAPITAL
- Global Brain Corporation
- KDDI Corporation
- The University of Tokyo Edge Capital Partners
- ITOCHU Technology Ventures, Inc.
By taking full advantage of the broad networks and deep expertise owned by these corporations, EditForce continues to make endeavors to develop our pipelines asl well as successfully apply the unique PPR technology worldwide in pharmaceutical fields.
For details, see EditForce completed fund raising by third-party allotment (PDF)
Archives